Literature DB >> 29290517

Experimental and density functional theory studies on benzalkonium ibuprofenate, a double active pharmaceutical ingredient.

K P Safna Hussan1, M Shahin Thayyil1, Vijisha K Rajan2, K Muraleedharan3.   

Abstract

Molecular aspects of a double active pharmaceutical ingredient in ionic liquid form, benzalkonium ibuprofenate (BaIb), were studied using density functional theory (DFT/B3LYP/6-31+G (d, p)). A detailed discussion on optimized geometry, energy, heat and the enthalpy of BaIb was carried out. The computed vibrational results agree well with the experimental results. The stability and biological activity were compared to the parent drugs on the basis of global descriptive parameters. The electrophilic and nucleophilic sites were pointed out in the MESP structures well evidently. NBO analysis was also done to predict the relative aromaticity, delocalization effects and the contribution towards stabilization energy of the title compound. The information about non-covalent, non-ionic weak interaction between the cation and anion was obtained from the list of Mulliken charges and NBO analysis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Benzalkonium ibuprofenate; Density functional theory; Double active pharmaceutical ingredient; Drugs; Ionic liquids; Molecular orbitals; Mulliken charges; NBO analysis

Mesh:

Substances:

Year:  2017        PMID: 29290517     DOI: 10.1016/j.compbiolchem.2017.12.004

Source DB:  PubMed          Journal:  Comput Biol Chem        ISSN: 1476-9271            Impact factor:   2.877


  2 in total

1.  Molecular dynamics and the translational-rotational coupling of an ionically conducting glass-former: amlodipine besylate.

Authors:  Safna Hussan K P; Mohamed Shahin Thayyil; S K Deshpande; Jinitha T V; Manoj K; K L Ngai
Journal:  RSC Adv       Date:  2018-06-06       Impact factor: 4.036

Review 2.  Recent Advances in Ionic Liquids in Biomedicine.

Authors:  Alexander M Curreri; Samir Mitragotri; Eden E L Tanner
Journal:  Adv Sci (Weinh)       Date:  2021-07-10       Impact factor: 16.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.